NCT04934605

Brief Summary

To explore the genotype-phenotype correlation of SLC26A4 mutations in cochlear-implanted patients with enlarged vestibular aqueduct.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2010

Longer than P75 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2010

Completed
11 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2021

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 10, 2021

Completed
12 days until next milestone

First Posted

Study publicly available on registry

June 22, 2021

Completed
9 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2021

Completed
Last Updated

June 22, 2021

Status Verified

April 1, 2021

Enrollment Period

11 years

First QC Date

June 10, 2021

Last Update Submit

June 21, 2021

Conditions

Keywords

enlarged vestibular aqueductSLC26A4cochlear implant

Outcome Measures

Primary Outcomes (2)

  • Cochlear implant age

    Age of cochlear implantation.

    Immediately after cochlear implantation

  • Duration of hearing loss

    Time between found of hearing loss and cochlear implantation.

    Immediately after cochlear implantation

Secondary Outcomes (2)

  • Type of initial hearing loss

    On the 1 day of recruitment.

  • Type of hearing loss progression

    Immediately after cochlear implantation

Interventions

Cochlear implantation

Eligibility Criteria

Age0 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Subjects with sensorineural hearing loss and enlarged vestibular aqueduct.

You may qualify if:

  • Bilateral severe-to-profound sensorineural hearing loss who received cochlear implantation.
  • Bilateral or unilateral enlarged vestibular aqueduct (EVA) with or without Mondini malformation (IP-II) on temporal bone computed tomography (CT) and/or magnetic resonance imaging (MRI).

You may not qualify if:

  • Hearing loss that is associated with symptoms which meet the criteria of already known syndromes.
  • With other type of inner ear malformation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Biospecimen

Retention: SAMPLES WITH DNA

Blood

MeSH Terms

Conditions

Hearing Loss, SensorineuralDeafness, Autosomal Recessive 4

Interventions

Cochlear Implantation

Condition Hierarchy (Ancestors)

Hearing LossHearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Otologic Surgical ProceduresOtorhinolaryngologic Surgical ProceduresSurgical Procedures, OperativeProsthesis Implantation

Study Officials

  • Xiao Liu, MD

    Department of Otorhinolaryngology, 2nd Affiliated Hospital, School of Medicine, Zhejiang University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 10, 2021

First Posted

June 22, 2021

Study Start

May 1, 2010

Primary Completion

May 1, 2021

Study Completion

July 1, 2021

Last Updated

June 22, 2021

Record last verified: 2021-04